Measurement of protease activity in vivo
Measurement of protease activity in vivo
批准号:
8238730
负责人:
Patrick S Daugherty
金额:
$41.29万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-15 至 2016-01-31
关键词:
Active SitesAddressAffinityAnimalsAntibodiesAntibody Binding SitesApolipoprotein EAtherosclerosisBindingBiological ProcessBlocking AntibodiesCardiovascular DiseasesCharacteristicsCommunicable DiseasesDataDetectionDevelopmentDiagnosticDiagnostic ImagingDiseaseEngineeringEnzymesEventExhibitsFamilyFluorescence Resonance Energy TransferGeneric DrugsHalf-LifeHealthHomologous GeneHourHumanImageImmunofluorescence ImmunologicImmunoglobulin GIn VitroIndividualInflammatoryLifeLigandsMMP14 geneMagnetic Resonance ImagingMalignant NeoplasmsMasksMeasurementMeasuresMediatingMethodsMolecular ProbesMusOrganismPathogenesisPathologicPathologic ProcessesPeptide HydrolasesPeptide LibraryPeptide antibodiesPeptidesPerformancePhysiologicalPhysiological ProcessesPlayPositron-Emission TomographyProcessRegulationReportingRoleSiteSpecificityThrombinTissuesTranslatingWhole OrganismYeastsbasedesigndirected evolutionflexibilityfluorescence imagingin vivomouse modelnovelnovel strategiesnovel therapeutic interventionpolymerizationscaffoldtooluptake
中文摘要
描述(由申请人提供):已知蛋白酶活性在包括癌症、心血管疾病以及炎性和感染性疾病在内的多种疾病的发病机理中是关键的。尽管大规模的努力提供了关于许多不同蛋白酶在正常和疾病组织中的表达的有价值的信息,但这些方法没有报道蛋白酶的功能活性。蛋白酶信标正在成为一种强有力的工具,非侵入性地测量体内蛋白酶活性,并将受益于方法,使更多的选择性切割个别靶向蛋白酶和探针保留在激活位点。该项目旨在验证一种通用的分子探针设计,以检测,定位和定量蛋白酶活性在体内正常和病理组织和整个生物体。具体而言,将产生一类新的蛋白酶活性探针,其表现出高组织摄取、通过单个靶蛋白酶的选择性活化和在活化位点的积累的期望特征。将在正常小鼠和动脉粥样硬化的ApoE(-/-)小鼠模型中证明这些探针用于体内蛋白酶活性的定位和定量的效用。该项目的完成将产生准确可靠地报告参与正常和病理过程的蛋白酶活性的探针,具有很高的翻译人类的潜力。更一般地说,成功完成本提案的目标将打开大门,以高的空间和时间精度的测量和定位的范围广泛的蛋白酶活性的活生物体。
公共卫生相关性:该项目旨在检测、定位和定量在疾病过程中起关键作用的一大类酶,以实现全新的治疗方法和诊断工具。我们将开发和验证分子探针,使测量两个蛋白酶的活动,在心血管疾病的进展中发挥关键作用。!
英文摘要
DESCRIPTION (provided by applicant): Protease activities are known to be critical in the pathogenesis of a wide variety of diseases including cancer, cardiovascular disease, and inflammatory and infectious diseases. Although large-scale efforts are providing valuable information regarding the expression of many diverse proteases in normal and disease tissues, these methods do not report the functional activity of proteases. Protease beacons are emerging as a powerful tool to non-invasively measure protease activity in vivo, and will benefit from approaches that enable more selective cleavage by individual targeted proteases and probe retention at the site of activation. This project aims to validate a generic molecular probe design to detect, localize, and quantify protease activities in vivo in normal and pathologic tissues and whole organisms. Specifically, a new class of protease activity probes will be created that exhibit the desired characteristics of high tissue uptake, selective activation by individual target proteases, and accumulation at sites of activation. The utility of these probes for the localization and quantification of protease activities in vivo will be demonstrated in normal mice and the ApoE(-/-) mouse model of atherosclerosis. Completion of this project will yield probes that accurately and reliably report the activity of proteases involved in normal and pathologic processes, with high potential for translational to humans. More generally, successful completion of the aims of this proposal will open the door to the measurement and localization of a wide range of protease activities in living organisms with high spatial and temporal precision.
PUBLIC HEALTH RELEVANCE: This project aims to enable the detection, localization and quantification of a large class of enzymes that play key roles in disease processes, to enable completely new therapeutic approaches and diagnostic tools. We will develop and validate molecular probes that enable measurement of two protease activities that play crucial roles in the progression of cardiovascular disease. !
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Digital serology for parallel parasitic disease detection
-
批准号:9255416
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:Patrick S Daugherty
-
依托单位:
Measurement of protease activity in vivo
-
批准号:8795724
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2012
-
负责人:Patrick S Daugherty
-
依托单位:
Serine protease zymogen activation by small molecules
-
批准号:8460829
-
项目类别:
-
资助金额:$3.71万
-
财政年份:2012
-
负责人:Patrick S Daugherty
-
依托单位:
Serine protease zymogen activation by small molecules
-
批准号:8328055
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2012
-
负责人:Patrick S Daugherty
-
依托单位:
Measurement of protease activity in vivo
-
批准号:8607966
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2012
-
负责人:Patrick S Daugherty
-
依托单位:
Measurement of protease activity in vivo
-
批准号:8427291
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:Patrick S Daugherty
-
依托单位:
Biomolecular probes for imaging protease activities
-
批准号:8333951
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Antibody Reprtoire Characterization in Celiac Disease
-
批准号:8602819
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Antibody Reprtoire Characterization in Celiac Disease
-
批准号:8796822
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Biomolecular probes for imaging protease activities
-
批准号:8096334
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Antibody Reprtoire Characterization in Celiac Disease
-
批准号:8212105
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Antibody Reprtoire Characterization in Celiac Disease
-
批准号:8025324
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Antibody Reprtoire Characterization in Celiac Disease
-
批准号:8414834
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2011
-
负责人:Patrick S Daugherty
-
依托单位:
Quantitative Serum Antibody Specificity Screening in Celiac Disease
-
批准号:7531456
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2008
-
负责人:Patrick S Daugherty
-
依托单位:
Quantitative Serum Antibody Specificity Screening in Celiac Disease
-
批准号:7673756
-
项目类别:
-
资助金额:$17.75万
-
财政年份:2008
-
负责人:Patrick S Daugherty
-
依托单位:
海外基金